New Jersey Gov. Chris Christie this week signed legislation allowing pharmacists to subsistute FDA-approved biosimilar products for biologics, and Generic Pharmaceutical Association voiced its support for the move.
Cardinal Health's Brad Tice on Friday published a blog outlining the first steps payers are taking to reimburse for medication therapy management. "The take-away from these new developments is that payers - both government and private - recognize that reimbursement practices need to change, and MTM services are in the middle of that change," he wrote. "Yet the second and third acts are still to come. Hold your standing ovation until then. (Cardinal Health)
GlaxoSmithKline is celebrating 300 years. Originating as a small pharmacy in East London in 1715, GlaxoSmithKline has grown into the sixth largest global pharmaceutical company, the International Business Times reported Monday. "I'm extremely proud of all the history we have behind us," noted Nikki Yakes, GSK UK Pharma general manager. "It is a quite remarkable achievement to be able to trace our roots back to one young entrepreneur in 1715." (International Business Times)
Based on the company’s presentation accompanying a conference call on the acquisition, AstraZeneca’s focus to be on the treatment ZS Pharma is developing for hyperkalemia, a side effect of chronic kidney disease,